AUPP751398A0 - Methotrexate derivatives - Google Patents

Methotrexate derivatives

Info

Publication number
AUPP751398A0
AUPP751398A0 AUPP7513A AUPP751398A AUPP751398A0 AU PP751398 A0 AUPP751398 A0 AU PP751398A0 AU PP7513 A AUPP7513 A AU PP7513A AU PP751398 A AUPP751398 A AU PP751398A AU PP751398 A0 AUPP751398 A0 AU PP751398A0
Authority
AU
Australia
Prior art keywords
methotrexate derivatives
methotrexate
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP7513A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Priority to AUPP7513A priority Critical patent/AUPP751398A0/en
Publication of AUPP751398A0 publication Critical patent/AUPP751398A0/en
Priority to KR1020017006889A priority patent/KR20010081050A/en
Priority to EP99960710A priority patent/EP1135390A1/en
Priority to AU17615/00A priority patent/AU1761500A/en
Priority to PCT/AU1999/001073 priority patent/WO2000034281A1/en
Priority to JP2000586727A priority patent/JP2002531566A/en
Priority to CN99815957A priority patent/CN1334815A/en
Priority to CA002353839A priority patent/CA2353839A1/en
Priority to ZA200104533A priority patent/ZA200104533B/en
Priority to NO20012720A priority patent/NO20012720L/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AUPP7513A 1998-12-04 1998-12-04 Methotrexate derivatives Abandoned AUPP751398A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AUPP7513A AUPP751398A0 (en) 1998-12-04 1998-12-04 Methotrexate derivatives
CA002353839A CA2353839A1 (en) 1998-12-04 1999-12-03 Methotrexate derivatives
PCT/AU1999/001073 WO2000034281A1 (en) 1998-12-04 1999-12-03 Methotrexate derivatives
EP99960710A EP1135390A1 (en) 1998-12-04 1999-12-03 Methotrexate derivatives
AU17615/00A AU1761500A (en) 1998-12-04 1999-12-03 Methotrexate derivatives
KR1020017006889A KR20010081050A (en) 1998-12-04 1999-12-03 Methotrexate derivatives
JP2000586727A JP2002531566A (en) 1998-12-04 1999-12-03 Methotrexate derivative
CN99815957A CN1334815A (en) 1998-12-04 1999-12-03 Methotrexate derivatives
ZA200104533A ZA200104533B (en) 1998-12-04 2001-06-01 Methotrexate derivatives.
NO20012720A NO20012720L (en) 1998-12-04 2001-06-01 Methotrexate derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP7513A AUPP751398A0 (en) 1998-12-04 1998-12-04 Methotrexate derivatives

Publications (1)

Publication Number Publication Date
AUPP751398A0 true AUPP751398A0 (en) 1999-01-07

Family

ID=3811723

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP7513A Abandoned AUPP751398A0 (en) 1998-12-04 1998-12-04 Methotrexate derivatives

Country Status (9)

Country Link
EP (1) EP1135390A1 (en)
JP (1) JP2002531566A (en)
KR (1) KR20010081050A (en)
CN (1) CN1334815A (en)
AU (1) AUPP751398A0 (en)
CA (1) CA2353839A1 (en)
NO (1) NO20012720L (en)
WO (1) WO2000034281A1 (en)
ZA (1) ZA200104533B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958632A1 (en) * 2007-02-14 2008-08-20 Dan Stoicescu Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases
CN101926860A (en) * 2010-05-07 2010-12-29 宁波立华制药有限公司 Peony extract-methotrexate composition, preparation method thereof and use thereof
CN110174363A (en) * 2019-01-09 2019-08-27 北京九强生物技术股份有限公司 Glucose-6-phosphate dehydrogenase mutant and its purposes in preparation detection reagent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004030A1 (en) * 1993-08-02 1995-02-09 Commonwealth Scientific And Industrial Research Organisation Therapeutic compound - fatty acid conjugates
US5952499A (en) * 1995-01-16 1999-09-14 Commonwealth Scientific And Industrial Research Organisation Therapeutic compound-fatty acid conjugates

Also Published As

Publication number Publication date
EP1135390A1 (en) 2001-09-26
NO20012720L (en) 2001-07-31
WO2000034281A1 (en) 2000-06-15
KR20010081050A (en) 2001-08-25
ZA200104533B (en) 2002-06-03
NO20012720D0 (en) 2001-06-01
CN1334815A (en) 2002-02-06
JP2002531566A (en) 2002-09-24
CA2353839A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
AU5759999A (en) Pyrimidone derivatives
AU1151099A (en) Azaoxindole derivatives
AU1977699A (en) Phenylalanine derivatives
AU1825899A (en) Dota-biotin derivatives
AU7935398A (en) Diaminorhodamine derivatives
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
AU5065999A (en) Naphthyridine derivatives
AU1379900A (en) Novel substituted phenyloxazolidone derivatives
AU7813598A (en) Betulinol derivatives
AU3167699A (en) Vitamin d derivatives substituted at the 2beta-position
AU1174199A (en) Biphenylamidine derivatives
AU6729498A (en) Thiazolimine derivatives
AU1223400A (en) Novel pterin antineoplastic agents
AU6228299A (en) 2-substituted-d-homooxasteroid derivatives
AU2275999A (en) Substituted guanidine derivatives
AU5515299A (en) 9-dialkylamino purinone derivatives
AU1562199A (en) Amino-benzothiazole derivatives
AU6115798A (en) Saponarin derivatives
AU2640999A (en) 1-azaindolizine derivatives
AUPP751398A0 (en) Methotrexate derivatives
AU4141099A (en) Pyrazolyldioxothiochromanoyl derivatives
AU2894099A (en) Phenanthrofuran derivatives
AU5239899A (en) Amidophosphate derivatives
AU5411499A (en) Piperazinone derivatives
AU1691399A (en) 5-arylpyrrole derivatives

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 1761500

Country of ref document: AU